Eli Lilly's Alzheimer's Drug Raises Hopes but Faces Regulatory Hurdles in Europe
On Monday, Eli Lilly And Co (NYSE:LLY) announced plans to boost its presence in the U.K., following a collaboration with the U.K. government that was revealed at the International Investment Summit. The global pharmaceutical giant is set to invest in a new Gateway Lab in the U.